| Variables | NCDB Long Term Outcomes | Open, N = 6,4341 | p-value2 | |
|---|---|---|---|---|
| Overall, N = 11,2691 | MIS, N = 4,8351 | |||
| Age | 64.00 (55.00, 72.00) | 64.00 (55.00, 73.00) | 65.00 (55.00, 72.00) | 0.84 |
| Sex | 0.16 | |||
| Female | 5,727 (51%) | 2,420 (50%) | 3,307 (51%) | |
| Male | 5,542 (49%) | 2,415 (50%) | 3,127 (49%) | |
| Race | <0.001 | |||
| Black | 1,330 (12%) | 507 (10%) | 823 (13%) | |
| Other | 623 (5.5%) | 298 (6.2%) | 325 (5.1%) | |
| White | 9,316 (83%) | 4,030 (83%) | 5,286 (82%) | |
| Insurance Status | <0.001 | |||
| Medicaid | 610 (5.4%) | 244 (5.0%) | 366 (5.7%) | |
| Medicare | 5,346 (47%) | 2,294 (47%) | 3,052 (47%) | |
| Not Insured | 256 (2.3%) | 78 (1.6%) | 178 (2.8%) | |
| Private Insurance/Managed Care/Goverment | 4,946 (44%) | 2,178 (45%) | 2,768 (43%) | |
| Unknown | 111 (1.0%) | 41 (0.8%) | 70 (1.1%) | |
| Region | <0.001 | |||
| Midwest | 2,726 (26%) | 1,120 (25%) | 1,606 (26%) | |
| NorthEast | 2,652 (25%) | 1,273 (28%) | 1,379 (23%) | |
| South | 3,832 (36%) | 1,543 (34%) | 2,289 (38%) | |
| West | 1,459 (14%) | 631 (14%) | 828 (14%) | |
| Unknown | 600 | 268 | 332 | |
| Income | 0.003 | |||
| < $38,000 | 1,691 (15%) | 670 (14%) | 1,021 (16%) | |
| >=$63,000 | 4,219 (38%) | 1,881 (39%) | 2,338 (36%) | |
| $38,000-$47,999 | 2,410 (21%) | 1,005 (21%) | 1,405 (22%) | |
| $48,000-$62,999 | 2,929 (26%) | 1,271 (26%) | 1,658 (26%) | |
| Unknown | 20 | 8 | 12 | |
| No High School Degree | <0.001 | |||
| <7.0% | 3,235 (29%) | 1,426 (30%) | 1,809 (28%) | |
| >=21.0% | 1,606 (14%) | 653 (14%) | 953 (15%) | |
| 13.0-20.9% | 2,698 (24%) | 1,090 (23%) | 1,608 (25%) | |
| 7.0-12.9% | 3,716 (33%) | 1,659 (34%) | 2,057 (32%) | |
| Unknown | 14 | 7 | 7 | |
| Population | 0.19 | |||
| Metro | 9,391 (86%) | 4,047 (86%) | 5,344 (85%) | |
| Rural | 98 (0.9%) | 35 (0.7%) | 63 (1.0%) | |
| Urban | 1,490 (14%) | 619 (13%) | 871 (14%) | |
| Unknown | 290 | 134 | 156 | |
| Charlson-Deyo Disability Score | 0.86 | |||
| >=3 | 389 (3.5%) | 168 (3.5%) | 221 (3.4%) | |
| 0 | 7,239 (64%) | 3,120 (65%) | 4,119 (64%) | |
| 1 | 2,920 (26%) | 1,248 (26%) | 1,672 (26%) | |
| 2 | 721 (6.4%) | 299 (6.2%) | 422 (6.6%) | |
| Staging | <0.001 | |||
| Stage 0 | 423 (4.1%) | 186 (4.1%) | 237 (4.1%) | |
| Stage I | 4,470 (43%) | 2,186 (48%) | 2,284 (39%) | |
| Stage II | 5,268 (51%) | 2,143 (47%) | 3,125 (54%) | |
| Stage III | 194 (1.9%) | 48 (1.1%) | 146 (2.5%) | |
| Unknown | 914 | 272 | 642 | |
| Tumor Grade | <0.001 | |||
| Moderately differentiated | 3,550 (32%) | 1,428 (30%) | 2,122 (33%) | |
| Poorly differentiated | 1,751 (16%) | 645 (13%) | 1,106 (17%) | |
| Undifferentiated | 159 (1.4%) | 65 (1.3%) | 94 (1.5%) | |
| Unknown | 1,618 (14%) | 633 (13%) | 985 (15%) | |
| Well differentiated | 4,191 (37%) | 2,064 (43%) | 2,127 (33%) | |
| Median Survival | 26.48 (13.24, 45.11) | 27.33 (14.72, 44.12) | 25.92 (12.29, 45.83) | 0.038 |
| Unknown | 1,911 | 1,006 | 905 | |
| Vital Status | <0.001 | |||
| Alive | 5,787 (62%) | 2,682 (70%) | 3,105 (56%) | |
| Dead | 3,571 (38%) | 1,147 (30%) | 2,424 (44%) | |
| Unknown | 1,911 | 1,006 | 905 | |
|
1
Statistics presented: Median (IQR); n (%)
2
Statistical tests performed: Wilcoxon rank-sum test; chi-square test of independence
|
||||